Eye vitamin supplements genuinely reduce the risk of vision loss from age-related macular degeneration, at least for people who already have intermediate or advanced disease. That finding comes from two of the largest and longest-running eye supplement trials ever conducted, and it remains one of the clearest wins in the supplement world. But the story gets more complicated fast. For other eye conditions like dry eye, cataracts, and screen fatigue, the evidence ranges from weak to flatly negative, and some supplements can cause harm in people with certain risk factors.
The AREDS Trials Changed the Conversation
Most of what we know about eye vitamins traces back to two government-funded studies known as AREDS and AREDS2. The original Age-Related Eye Disease Study ran from the early 1990s through the 2000s and tested a specific combination of vitamin C, vitamin E, beta-carotene, zinc, and copper in people with various stages of age-related macular degeneration (AMD). AMD is the leading cause of irreversible vision loss in older adults, and at the time, there was no proven way to slow its progression.
The results were striking. Among participants who already had intermediate or advanced AMD in one eye, those taking the AREDS formula had roughly a 25% lower risk of progressing to advanced disease compared to placebo. Long-term follow-up at ten years found that the supplement group had about a 34% lower odds of developing advanced AMD and a 40% lower odds of the most severe form involving abnormal blood vessel growth.1Ophthalmology. Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-related Macular Degeneration: AREDS Report No. 35 That is a meaningful, durable benefit, and it holds up after a decade of follow-up.
There is an important caveat, though. The AREDS formula helped people who already had moderate or worse AMD. It did not prevent AMD from developing in the first place in people with healthy eyes or only very early signs of the disease. If you have been diagnosed with intermediate AMD by an eye doctor, AREDS-type supplements have solid evidence behind them. If your eyes are healthy and you are taking them “just in case,” the trials did not show a benefit for that scenario.
Why the Original Formula Was Replaced
The original AREDS formula contained beta-carotene, which turned out to be a problem. Two earlier randomized trials had already linked beta-carotene supplements to increased lung cancer risk in smokers, and that concern carried over into eye research. AREDS2, which ran from 2006 to 2012 and enrolled patients with intermediate AMD, tested whether swapping beta-carotene for lutein and zeaxanthin would maintain the protective effect while eliminating the cancer risk.
The swap worked. AREDS2 found that lutein and zeaxanthin performed at least as well as beta-carotene for slowing AMD progression, with a particular advantage in people whose diets were already low in these nutrients.2PubMed Central. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28 And the lung cancer signal was confirmed: at ten years, participants who had been randomly assigned to beta-carotene had roughly double the odds of developing lung cancer compared to those assigned to lutein and zeaxanthin. Critically, the increased lung cancer risk affected former smokers too, not just current ones.3JAMA. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
The practical upshot: if you see an eye vitamin on the shelf that still lists beta-carotene as an ingredient, it is using an outdated formula. The current recommended version, sometimes marketed as “AREDS2 formula,” uses lutein and zeaxanthin instead. If you are a current or former smoker, the distinction matters for your safety, not just your eyes.
What Lutein and Zeaxanthin Actually Do in the Eye
Lutein and zeaxanthin are carotenoid pigments that concentrate in the macula, the small central region of the retina responsible for sharp, detailed vision. They form a yellowish layer called macular pigment that acts as a kind of internal sunscreen, filtering high-energy blue light and neutralizing oxidative stress from light exposure. The density of this pigment layer varies from person to person, and thicker pigment is generally associated with better macular health.
Supplementation reliably increases macular pigment density. A systematic review and meta-analysis found that daily doses in the range of 5 to 20 milligrams raised macular pigment optical density by a modest but measurable amount, and higher doses produced larger increases.4PubMed Central. The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis The buildup is not instant. Serum levels of these carotenoids reach a plateau that corresponds to the dose taken, and the rate of pigment accumulation in the retina tracks with those serum concentrations.5The Journal of Nutrition. Lutein and Zeaxanthin Dietary Supplements Raise Macular Pigment Density and Serum Concentrations of these Carotenoids in Humans Most studies showing meaningful changes ran for several months, so this is not a supplement you take for a week and expect results from.
Whether more macular pigment translates into better everyday vision for someone with healthy eyes is a separate question, and the evidence there is thinner. The strongest case for supplementation remains in people with AMD or at high risk for it.
Omega-3s for Dry Eye Fell Flat
Omega-3 fatty acids, especially fish oil, are among the most commonly marketed supplements for dry eye. The logic sounds reasonable: omega-3s have anti-inflammatory properties, and dry eye involves chronic inflammation of the eye surface. Smaller studies had suggested a benefit, and many ophthalmologists were recommending fish oil to dry eye patients. Then a large, well-designed trial called DREAM put the claim to a rigorous test.
The results were disappointing. Over twelve months, participants taking omega-3 supplements showed no meaningful improvement in dry eye symptoms or clinical signs compared to those taking a placebo. Symptom scores, corneal staining, tear breakup time, and tear production all improved in both groups by similar amounts, which is the hallmark of a placebo response.6PubMed Central. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease An extension study followed a subset of participants out to 24 months and found the same pattern: no difference between omega-3 and placebo groups on any outcome measured.7PubMed Central. The Dry Eye Assessment and Management (DREAM) extension study – A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease
This does not mean dry eye is untreatable. Prescription anti-inflammatory eye drops, punctal plugs, and environmental changes like humidifiers have evidence behind them. But over-the-counter omega-3 capsules, which are often the first thing people reach for, did not outperform olive oil placebo capsules in the largest trial to date. If you have been taking fish oil specifically for dry eye and have not noticed an improvement, the science suggests you are not imagining things.
What About Cataracts
Cataracts are the most common cause of reversible vision loss worldwide, so it is natural to wonder whether antioxidant supplements could prevent or slow them. The picture here is genuinely mixed, and the answer depends on whether you are looking at supplement trials or long-term observational data.
On the trial side, a randomized study in South India tested whether supplementation with beta-carotene and vitamins C and E could slow cataract progression. It found no benefit: the supplement and placebo groups progressed at the same rate.8PubMed Central. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India AREDS itself also failed to show a clear effect on cataracts.
But observational data tells a different story. A population-based study found that people who reported using multivitamins or supplements containing vitamin C or E for more than ten years had a 60% lower risk of developing any cataract compared to nonusers. The association held for nuclear and cortical cataracts specifically, though not for the posterior subcapsular type. And shorter durations of use showed no benefit at all.9PubMed. Vitamin supplement use and incident cataracts in a population-based study
How do you square these findings? Observational studies cannot prove causation. People who take vitamins for ten-plus years tend to differ from nonusers in many ways: they eat better, exercise more, see doctors regularly. Those lifestyle differences could explain some or all of the lower cataract risk. The randomized trials, which can isolate the effect of the supplement itself, have not shown a benefit. Until a long-duration randomized trial of antioxidants and cataracts is conducted, the honest answer is that we do not know whether supplements help here, and the shorter trials suggest they do not.
Screen Time and Eye Strain Supplements
A growing category of eye supplements targets digital eye strain, the fatigue and discomfort that comes from hours of screen use. These products often feature lutein and zeaxanthin with the pitch that they filter blue light internally. The research here is still thin.
One randomized, double-blind trial tested a lutein and zeaxanthin supplement in heavy screen users over six months. The study did find a statistically significant difference between groups in photostress recovery time, which measures how quickly your vision bounces back after exposure to bright light. But when you look at the individual group changes, neither the supplement group’s improvement nor the placebo group’s worsening reached statistical significance on their own.10Frontiers in Nutrition. The effects of lutein/ zeaxanthin (Lute-gen®) on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomized, double-blind, placebo-controlled study That is the kind of result that warrants further study but does not constitute strong evidence of a real-world benefit you would notice.
The honest recommendation for screen-related eye strain remains decidedly low-tech: the 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds), proper screen brightness, adequate blinking, and good ambient lighting. These cost nothing and address the actual cause, which is prolonged near-focus and reduced blink rate, rather than any nutritional deficiency.
Can Eye Vitamins Hurt You
The beta-carotene and lung cancer story is the most dramatic safety concern, but it is not the only one. A study of people with diabetes found that higher intakes of antioxidant nutrients, including vitamins C, E, and beta-carotene, were associated with increased severity of diabetic retinopathy, not decreased severity. The association varied depending on whether participants were taking insulin, but no protective effect was observed for any antioxidant nutrient studied.11Ophthalmology. Antioxidant nutrient intake and diabetic retinopathy: The San Luis Valley Diabetes Study
This finding comes from an observational study, not a randomized trial, so it does not prove the vitamins caused the worsening. But it underscores a point that supplement marketers rarely emphasize: the biology of eye diseases is not all the same. A supplement formulated for AMD is not necessarily appropriate for someone with diabetic eye disease, and there is reason to be cautious. The broader oxidative-stress connection in diabetic retinopathy is an active research area, but the current state of the evidence does not support taking antioxidant supplements to prevent or treat it.12PubMed Central. Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials
High-dose zinc, which is part of the AREDS formula, can also cause copper deficiency if taken long-term, which is why the formulation includes copper. And like any supplement, eye vitamins can interact with prescription medications. If you are on blood thinners, for instance, high-dose vitamin E deserves a conversation with your doctor.
Food Sources Versus Pills
Your body absorbs lutein and zeaxanthin from food, and in some cases it absorbs them better from certain foods than from supplement capsules. A study comparing lutein sources found that lutein-enriched eggs produced higher serum lutein levels than either supplement pills or spinach, likely because the fat in egg yolk helps with absorption.13The Journal of Nutrition. Lutein Bioavailability Is Higher from Lutein-Enriched Eggs than from Supplements and Spinach in Men Another study found that a vegetable extract and spinach both produced elevated blood lutein levels lasting up to 80 hours from a single dose, suggesting that whole-food sources can deliver sustained carotenoid availability.14PubMed. Comparison of lutein bioavailability from vegetables and supplement
The richest dietary sources of lutein and zeaxanthin are dark leafy greens like kale, spinach, and collard greens, along with corn, orange peppers, and egg yolks. Eating these foods cooked or paired with some dietary fat improves absorption. For people who eat a varied diet with regular servings of colorful vegetables, supplements may not add much. Supplements fill a gap most clearly for people who have diagnosed AMD and need the specific high doses used in the AREDS trials, which are difficult to reach through food alone.
Emerging Research in Glaucoma
Glaucoma is a different animal from AMD. It involves progressive damage to the optic nerve, usually related to elevated eye pressure, and the standard treatments are pressure-lowering eye drops or surgery. Nutritional supplements have not traditionally been part of glaucoma management, but a line of research involving nicotinamide (a form of vitamin B3) has attracted serious attention.
A phase 2 clinical trial tested high-dose nicotinamide combined with pyruvate in people with open-angle glaucoma and found that treated eyes were roughly three times more likely to show improvement on visual field testing compared to placebo eyes.15JAMA Ophthalmology. Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial Animal research supports the mechanism: nicotinamide boosts levels of NAD, a molecule critical for cellular energy metabolism, and in glaucoma mouse models, chronic nicotinamide supplementation substantially reduced retinal ganglion cell loss and optic nerve degeneration.16Trends in Pharmacological Sciences. Glaucoma: neuroprotection with NAD-based therapeutic interventions
This is promising but early. The human trial was small and relatively short, and nicotinamide is not yet included in any clinical guidelines for glaucoma treatment. Larger, longer trials are underway. For now, it is worth knowing about if you have glaucoma, but it is not something to start taking without discussing it with your ophthalmologist, and it should never replace standard pressure-lowering therapy.
Astaxanthin and the Expanding Supplement Shelf
Beyond the AREDS nutrients, the supplement industry markets a growing list of compounds for eye health, including astaxanthin, bilberry extract, saffron, and ginkgo biloba. Most of these have little rigorous evidence behind them.
Astaxanthin, a red carotenoid found in salmon and shrimp, is one of the more studied alternatives. A randomized trial in healthy adults found that six weeks of astaxanthin supplementation appeared to reduce near-vision decline after sustained screen work, but only in the subgroup aged 40 and older, and the changes in visual acuity were extremely small.17PubMed Central. Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study This is far from the evidence base supporting AREDS-formula supplements for AMD. One small trial with a subgroup finding does not justify the price tag most astaxanthin eye supplements command.
The pattern repeats across much of the eye supplement market. A single positive pilot study or cell-culture experiment gets amplified into marketing claims, while the large, rigorous trials that could actually confirm or refute the benefit have not been done. The AREDS and AREDS2 trials stand out precisely because they were large, long, well-designed, and government-funded rather than industry-funded. When evaluating any eye supplement, a useful question is: has this been tested in a trial anywhere close to that scale? For most products on the shelf, the answer is no.
Who Should Actually Take Eye Vitamins
The clearest evidence supports AREDS2-formula supplements for people with intermediate AMD or advanced AMD in one eye. If an eye doctor has told you that you have drusen, pigment changes, or geographic atrophy, ask specifically whether an AREDS2 supplement is appropriate for your stage of disease. These supplements are not prescription-only and are widely available, but the starting point should be a clinical diagnosis, not a self-assessment.
For everyone else, the evidence is weaker or absent. If you have healthy eyes and want to protect them long-term, the most evidence-backed strategies are not supplements but behaviors: not smoking, wearing UV-blocking sunglasses, eating a diet rich in leafy greens and fish, managing blood pressure and blood sugar, and getting regular dilated eye exams after age 50. These are not glamorous, and they do not come in a bottle with a label promising “crystal-clear vision,” but they are what the research consistently supports.
People with diabetes should be especially cautious about eye supplements. The antioxidant combinations tested in AMD trials have not been shown to help diabetic retinopathy, and some observational data suggests they could worsen it. The best protection against diabetic eye disease is tight blood sugar control and regular retinal screening, not over-the-counter vitamins.
If you are already spending money on an eye supplement, check what is in it. A product containing the AREDS2 formula (vitamin C, vitamin E, lutein, zeaxanthin, zinc, and copper in the studied doses) has evidence behind it for AMD. A product containing beta-carotene is using an outdated and potentially dangerous formulation. And a product built around bilberry, astaxanthin, or proprietary blends is selling you hope with minimal clinical data to back it up.